CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial...
Phase 2
Saint Louis, Missouri, United States and 2 other locations
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
Saint Louis, Missouri, United States and 19 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Saint Louis, Missouri, United States and 66 other locations
Patients with inoperable endometrial cancer have limited treatment options. PD-L1 expression is common in endometrial cancers...
Phase 1
Saint Louis, Missouri, United States
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Saint Louis, Missouri, United States and 82 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Saint Louis, Missouri, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Saint Louis, Missouri, United States and 75 other locations
antigen (HLA) and MAGE-A4 tumor antigen. Tumor indications include endometrial, esophageal, esophagogastric junction (EGJ), gastric, head an....
Phase 1
Saint Louis, Missouri, United States and 21 other locations
This study is a first-in-human (FIH), Phase 1a/1b study of BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), to assess the safety, tolerabilit...
Phase 1
Saint Louis, Missouri, United States and 4 other locations
This is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb23104, to describe safety and tolerability, t...
Phase 1
Saint Louis, Missouri, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal